Combiphar has since continued to touch the lives of the Indonesian people. Today, more and more individuals and families are feeling the benefits from Combiphar’s products and healthy lifestyle educations. Today, Combiphar produces and distributes more than 80 affordable prescription and over-the-counter drugs to its consumers, including OBH Combi cough syrup and Insto eye drops. The various brands of medication produced and marketed by Combiphar each contribute an important role in their respective categories. Numerous initiatives to support various communities and professional medical practitioners have also been introduced as Combiphar’s commitment to the health of the nation.
The Medical Affairs Manager will support the Medical Division in medical insight matters, review products for new product development or existing products, assess causal relationships of adverse events, evaluate clinical results from published journals or articles, and have knowledge of Pharmacovigilance, Pharmaceutical Industries, and Clinical Trials.
Responsibilities
• Support Medical Division for medical insight matters
• Product/molecule review for NPD and/or existing products
• Assessment of of causal relationship of adverse events
• Assessment of clinical result from published journals and/or article
• Having knowledge & understanding about Pharmacovigilance, Pharmaceutical Industries, Clinical Trial Knowledge
Requirements
• Medical Doctor (preferable as active Medical Doctor)
• Having minimum 3 year(s) of working experience as Medical Marketing/Medical Affairs with pharmaceutical product
• Having excellent communication, interpersonal, positive attitude toward works and able to work in dynamic environment
• Self-motivated and team work personality
• Fluent in English (oral & written)
Benefits
Huneety A.I Salary Estimate
11,000,000 - 35,000,000 IDR per month
You are about to leave Huneety to visit Jobstreet.co.id.
Before you leave...
We would like to invite you to create a profile so we can share all similar opportunities like this one in the future.
